EPPIC is a clinical study supported by the National Institute of Health. EPPIC is designed for people with moderate to severe symptoms of a cluster of urological disorders that include interstitial cystitis/bladder pain syndrome or chronic prostatitis/chronic pelvic pain syndrome.

Their symptoms – pain, urgency, and frequency – are not typically responsive to medical treatments but can respond quite well to science-based behavioral treatments used effectively with other pain disorders.

The opportunity to provide a safe, robust, and drug-free treatment for people suffer from refractory symptoms would represent a significant advance in our ability to manage chronic pelvic pain and relieve its day-to-day burden for millions desperate for help.